return to news
  1. Stocks to watch, Nov 4: Lupin, NSE, BSE, Nykaa, PFC, Premier Energies, Waaree Energies, Yatharth Hospital

Market News

Stocks to watch, Nov 4: Lupin, NSE, BSE, Nykaa, PFC, Premier Energies, Waaree Energies, Yatharth Hospital

Swati Verma

13 min read | Updated on November 04, 2026, 08:40 IST

SUMMARY

Pharma major Lupin on Wednesday posted a 22.19% decline in consolidated net profit to ₹1,155.30 crore in the September quarter (Q2 FY27), dragged down by an exceptional item.

Shares in focus, Nov 4, 2026

GIFT NIFTY futures suggest the NIFTY50 index will open 68 points lower. Image: Shutterstock

The domestic stock market is expected to open lower on Wednesday, November 4. GIFT NIFTY futures suggest the NIFTY50 index will open 68 points lower.

Here is a list of stocks that may remain in focus today.
Earnings today: More than 400 companies are slated to release their September quarter (Q2 FY27) numbers today.

The list includes BSE Ltd, Cummins India, Zydus Lifesciences, Apollo Hospitals Enterprises, Lenskart Solutions, FSN E-Commerce Ventures (Nykaa), Power Finance Corporation, Aurobindo Pharma, Dabur India, Torrent Power, Balkrishna Industries, and Premier Energies, among others.

Open FREE Demat Account within minutes!
Join now
Lupin: Pharma major Lupin on Wednesday posted a 22.19% decline in consolidated net profit to ₹1,155.30 crore in the September quarter (Q2 FY27), dragged down by an exceptional item.

The company had posted a net profit of ₹1,484.83 crore in the corresponding period of the previous fiscal year, it said in a regulatory filing to the exchanges.

Revenue from operations was ₹7,827.26 crore during the quarter under review, up from ₹7,047.51 crore in the year-ago period, it said.

Lupin's total expenses also rose to ₹6,374.46 crore during the quarter from ₹5,130.54 crore in the same period last year.

Yatharth Hospital and Trauma Care Services: The super speciality hospital chain on Tuesday reported a 17.45% rise in consolidated net profit to ₹48.45 crore during the September quarter. It had posted a profit of ₹41.25 crore in the year-ago period, according to a regulatory filing.

Revenue from operations rose to ₹431.42 crore during the period under review as against ₹28.3 crore a year ago.

The company's expenses also rose to ₹370.83 crore in the July-September period of FY27 from ₹234 crore in the year-ago period.

"Our quarterly revenue and profits have nearly tripled since our listing in 2023, reflecting our consistent record growth quarter-over-quarter. Our acquisitions since listing have also progressed strongly, now contributing 28% of group revenue and achieving EBITDA breakeven within a short period," Yatharth Tyagi, Whole Time Director, Yatharth Hospitals, said.

Multi Commodity Exchange of India (MCX): Shares of MCX will be in focus after the company reported a strong performance for Q2 FY27. Revenue from operations surged 113.9% year-on-year to ₹800 crore, while EBITDA jumped 145.9% to ₹664 crore. Net profit (PAT) rose 130.8% year-on-year to ₹455 crore.

The exchange’s average daily turnover (ADT) stood at ₹62,819 crore in futures and ₹12,00,129 crore in options during the quarter. MCX reported deliveries of 5.68 MT in gold, 199.91 MT in silver and 34,707 MT in base metals.

Evonile Pharma: Evonile Pharma, formerly Novartis India, on Tuesday reported a net loss of ₹77.54 crore in the September quarter, dragged down by exceptional items.

The pharma company posted a profit of ₹24.22 crore in the corresponding period of the previous fiscal year, according to a regulatory filing.

Its revenue from operations also declined to ₹56.05 crore during the period under review from ₹90.33 crore a year ago, it said.

The company's expenses rose to ₹96.59 crore in the second quarter of the current fiscal year from ₹67.08 crore a year earlier, it said.

Exceptional items for the quarter, aggregating to ₹68.26 crore, comprise ₹61 crore arising from the termination and related inventory purchase arrangements "with a major customer", the filing noted.

Prestige Estates: Realty firm Prestige Estates Projects Ltd on Tuesday said it has acquired 100% equity of Gloind Vintage Infra for an enterprise value of ₹519 crore.

In a regulatory filing, the company informed that its subsidiary Prestige Retail Ventures has acquired 100 per cent of the equity share capital of Gloind Vintage Infra Pvt Ltd.

The acquisition has been done from DSFF Series 2, a scheme of Dickey Special Situation Investment Trust, and Jasbir Singh, pursuant to a Securities Purchase Agreement dated November 3, 2026.

With this acquisition, Gloind has become a wholly owned step-down subsidiary of the company.

Metropolis Healthcare: Metropolis Healthcare on Tuesday posted a 42.71% rise in consolidated net profit to ₹75.48 crore in the September quarter, supported by higher revenue.

The company posted a net profit of ₹52.89 crore in the corresponding period of the previous fiscal year, according to a regulatory filing.

Its revenue from operations rose to ₹496.82 crore during the quarter under review from ₹429.19 crore a year earlier, it added.

In the first half of the current fiscal year, the company's net profit rose to ₹132.36 crore from ₹98.13 crore a year earlier.

Metropolis Healthcare's patient volume grew 10% to 4.1 million, while test volume increased 11% to 8.7 million.

Tata Motors Ltd: Tata Motors and Italian commercial vehicle maker Iveco Group are looking at significant growth in volumes, revenues and margins over the next five years as the two companies join hands to create a global commercial vehicle powerhouse, Tata Sons Chairman N Chandrasekaran said on Tuesday.

In a joint statement, the companies said, "Complementary portfolios and geographic strengths create a truly global enterprise, with presence in over 130 countries across key developed and high-growth markets in Europe, India, South America, Asia, the Middle East and Africa, and combined revenues of 21 billion euros (about ₹2,28,000 crore)".

Addressing a joint global press conference at Iveco's headquarters in Turin, Italy, Chandrasekaran said that together, Tata Motors Commercial Vehicles and Iveco would leverage the complementary geographical presence, product portfolios and technological capabilities to drive growth.

ASK Automotive: Auto component maker ASK Automotive Ltd on Tuesday reported a 27.3% YoY growth in net profit for the September quarter (Q2 FY27) on the back of robust growth in its top line and operating profit.

The company, which is known for brake shoes and advanced braking systems, clocked ₹101.6 crore in consolidated net profit for the quarter, against ₹79.80 crore in the year-ago period.

Revenue from operations in Q2 FY27 came in at ₹1,555.16 crore, compared to ₹1,053.70 crore in the year-ago period, the company said in a release.

Revenue from ABS grew more than 46 per cent while revenue from aluminium light weighting precision solutions and safety control cables rose over 69% and 33%, respectively.

The company noted that its export revenue more than doubled to ₹70 crore from ₹30 crore in the year-ago period.

V2 Retail: The company on Tuesday reported a 5.7% rise in net profit at ₹18.21 crore for the September quarter FY27.

The company had logged a net profit of ₹17.23 crore in the July-September period a year ago, according to a regulatory filing from V2 Retail, a value retailer.

Revenue from operations was at ₹905.59 crore in the September quarter of FY27 as against ₹708.63 crore a year ago. Total expenses were higher by 28.24% to ₹883.30 crore.

Total income, which includes other income, in the September quarter was at ₹908.08 crore, up 27.9%.

During April-September FY27, the total income was at ₹1,906.27 crore, up 41.9% YoY.

KEC International: The company's consolidated net profit plunged manifold to ₹30 crore in the September quarter, amid project execution challenges.

It had clocked a net profit of ₹161 crore in the second quarter of the preceding financial year, the company said in a statement on Tuesday.

During the July-September period of FY27, the company's revenue dropped to ₹5,468 crore, down 10% against ₹6,092 crore in the year-ago period.

Vimal Kejriwal, MD & CEO, KEC International commented, “We navigated a challenging operating environment during the quarter on account of continued geopolitical and supply chain disruptions in the Middle East, Right of Way (RoW) and land acquisition-related challenges in India T&D, and calibrated supplies of select projects amidst the elevated global cost environment.”

Northern Arc Capital: Non-banking lender Northern Arc Capital on Tuesday reported a 41% rise in profit to ₹129 crore for the second quarter ended September 2026.

The NBFC firm had earned a net profit of ₹92 crore in the same quarter a year ago.

Total income rose to ₹874 crore in the quarter from ₹629 crore in the year-ago period, Northern Arc Capital said in a regulatory filing.

Net interest income increased 32% to ₹425 crore from ₹322 crore in the same quarter of the previous fiscal year.

The NBFC’s total expenditure increased to ₹705 crore from ₹505 crore in the same period a year ago.

The capital adequacy ratio of the company stood at 20.8% as on September 30, 2026.

GSK Pharma: GlaxoSmithKline Pharmaceuticals Ltd on Tuesday reported a 30.44% rise in consolidated net profit to ₹335.88 crore in the September quarter, driven by strong growth in sales across verticals.

The pharma company had posted a net profit of ₹257.49 crore in the year-ago period, said a regulatory filing.

The company's total income rose to ₹1,256.35 crore during the second quarter of the ongoing fiscal year, compared to ₹1,013.51 crore a year earlier, it said.

Total expenses increased to ₹797 crore in Q2 FY27 from ₹662.15 crore a year ago, the filing said.

During the April-September period in FY27, the company's net profit rose nearly 24% to ₹573 crore from ₹462.50 crore in the corresponding period of the previous financial year.

NSE: The National Stock Exchange (NSE) on Tuesday reported a 23% increase in consolidated net profit at ₹2,578 crore for September quarter FY27 (Q2 FY27), driven by higher transaction revenue and a sharp decline in expenses.

The exchange had logged a profit after tax of ₹2,098 crore in the July-September period of the previous fiscal.

Total income rose 9% to ₹4,554 crore in the second quarter of FY27 from ₹4,160 crore a year ago, NSE said in a statement.

Revenue from transaction charges increased 9% to ₹3,035 crore during the quarter as compared to ₹2,789 crore in the year-ago period, driven by higher volumes in the cash market and equity options segments.

The cash market recorded an average daily traded volume (ADTV) of ₹1,18,377 crore, registering a 24% YoY growth. Meanwhile, ADTV for equity options (premium value) rose 3% to ₹47,977 crore.

Bata India: Leading shoemaker Bata India Ltd on Tuesday reported a 30.4% year-on-year rise in consolidated net profit to ₹18.11 crore in the September quarter of FY27, supported by higher average selling price (ASP).

It had posted a net profit of ₹13.89 crore in the July-September period a year ago, according to a regulatory filing from Bata India.

Revenue from operations was up 7.54% at ₹861.78 crore in the September quarter of FY27. It stood at ₹801.33 crore in the corresponding quarter a year ago.

The revenue was up 7.5% “despite the festive calendar largely deferring to Q3 this year”. Profit after tax for the quarter had “a growth of over 31%, supported by higher ASP”, the company said in its earnings statement.

Its total expenses in the September quarter stood at ₹855.14 crore, up 7.53% YoY.

Bata India's total income, which includes other income, soared 6.9% to ₹879.83 crore in the second quarter of FY27.

Global Health: Global Health, which runs a healthcare chain under the Medanta brand, on Tuesday posted a 38.34% rise in net profit to ₹219.14 crore during the September quarter, driven by strong growth in revenue.

The healthcare firm had logged a net profit of ₹158.40 crore in the year-ago period, the company said in a regulatory filing.

Its revenue from operations during the quarter under review stood at ₹1,469.04 crore, up from ₹1,099.28 crore in the year-ago period.

Its expenses during the July-September period also rose to ₹1,197.8 crore from ₹935.11 crore a year earlier, the filing noted.

BLS International Services: The company on Tuesday reported an 8.6% year-on-year growth in consolidated profit after tax at ₹201.7 crore during the quarter ended September 2026.

The company's PAT (profit after tax) stood at ₹185.7 crore during the corresponding quarter of last year, BLS International Services said in a regulatory filing.

Revenue from operations grew 32% to ₹972.7 crore during the quarter under review compared to ₹736.6 crore in the same period last year.

"The company is advancing its AI-led technology ecosystem and future-ready workforce through investments in automation, secure infrastructure, strategic partnerships and employee upskilling.

Indian Energy Exchange (IEX): The company on Tuesday said it has registered a 16.5% year-on-year growth in electricity traded volume to 13,092 million units (MUs) in October 2026.

The rise in power demand drove buy bids in the Day-Ahead Market, up 265% year-on-year, resulting in an increase in prices, an IEX statement said.

The average market clearing price in the Day-Ahead Market grew 149% to ₹6.66/unit in October 2026 from ₹2.67/unit in October 2025.

The sharp increase was also attributable to the low base of the corresponding month last year, when power demand was relatively lower.

Similarly, the average market clearing price in the Real-Time Market stood at ₹5.78/unit in October 2026, registering an increase of 112%.

Minda Corporation: Auto component major Minda Corporation Ltd reported a 68.2% year-on-year increase in consolidated net profit to ₹143 crore in the second quarter of the current fiscal year, driven by strong revenue growth.

The company had clocked a net profit of ₹85 crore in the July-September period of FY26.

Revenue from operations rose 42.6% YoY to ₹2,189 crore in the quarter under review.

"Q2 and H1FY27 reflected continued progress in our long-term growth strategy, driven by demand across key vehicle segments and execution across our businesses," the company's Chairman and group CEO Ashok Minda said.

Minda Corporation manufactures auto parts, such as switches, driver information systems, access control products, sensors, motors, turbochargers, EV powertrains, and fuel pumps across vehicle segments. Electric vehicle-related products accounted for around 35% of new order wins in the quarter.

Nexus Select Trust: The company on Tuesday reported an 8% increase in its net operating income (NOI) to ₹504 crore for the second quarter ended September 2026.

The company declared a distribution of ₹359 crore in the second quarter of this fiscal year, according to a regulatory filing.

"We have delivered a robust 13% year-on-year consumption growth during the quarter despite the festive season shifting largely to Q3 this year," Dalip Sehgal, Executive Director and CEO of Nexus Select Trust, said.

The performance reflects the resilience of the company's portfolio and the strength of operational execution in a challenging environment, he added.

Sehgal said the company has announced a distribution of ₹359 crore, equivalent to ₹2.367 per unit, reflecting 8% growth in DPU (distribution per unit).

Waaree Energies: Waaree Solar Americas Inc, a wholly-owned subsidiary of Waaree Energies Ltd (WEL), on Tuesday said that it has begun commercial production from two new solar module manufacturing lines at its facility in Brookshire, Texas.

Each line has an annual capacity of 800 MW. Together, they add 1.6 GW and take the facility's total annual installed capacity to 3.2 GW, a company statement said.

According to the statement, the Brookshire facility is one part of a wider US build-out. WSA is also upgrading its Arizona module facility from 1 GW to 1.6 GW, taking Waaree's planned US module capacity to 4.8 GW in FY27.

Across markets, the company's module order book stands at over 25 GW.

With inputs from PTI
Disclaimer: This article is written purely for informational purposes and should not be considered investment advice from Upstox. Please consult a financial advisor before making any investment decisions.

About The Author

Swati Verma
Swati Verma is a business journalist with 12 years of experience. She writes on equities, corporate earnings, sectoral trends, and industry outlook, among others. At Upstox, she leads financial markets coverage.

Next Story

End of additional stories